Amyloidosis

Amyloidosis is a rare and serious disease that could be fatal that is caused by accumulation of proteins in the form of abnormal, insoluble fibres, known as amyloid fibrils, within the tissues of the body.^[1]^[2]

Amyloid deposits can be confined to only one part of the body or a single organ system in 'local amyloidosis' or they can be widely distributed in organs and tissues throughout the body in 'systemic amyloidosis'. The symptoms of amyloidosis are accordingly highly variable and confirmation of the presence of amyloid in the tissues can be challenging, so that diagnosis is often delayed.

There are many different types of amyloidosis, each caused by formation of amyloid fibrils from different soluble precursor proteins in different patients.^[2]^[3] About 30 different proteins are known to form amyloid fibrils in humans^[4] and amyloidosis is named and classified according to the identity of the respective fibril protein.^[3]

Though this disease being rare, many famous people have died from this disease such as: Martin McGuinness, David Lange, Robert Jordan and Robert P. Casey.

Amyloidosis Media

Skin features of amyloidosis cutis dyschromica. Hyperpigmented and hypopigmented macules on (A) lower legs, (B) back and waist, (C) waist. (D) Individual blisters on upper arm.

References

↑ Wechalekar, Ashutosh D.; Gillmore, Julian D.; Hawkins, Philip N. (2015-12-21). "Systemic amyloidosis". Lancet (London, England). 387 (10038): 2641–2654. doi:10.1016/S0140-6736(15)01274-X. ISSN 1474-547X. PMID 26719234. S2CID 4762107.
↑ ^2.0 ^2.1 Pepys, Mark B. (2006-01-01). "Amyloidosis". Annual Review of Medicine. 57: 223–241. doi:10.1146/annurev.med.57.121304.131243. ISSN 0066-4219. PMID 16409147.
↑ ^3.0 ^3.1 Pepys MB and Hawkins PN, Amyloidosis (2010). Warrell, David A; Cox, Timothy M; Firth, John D (eds.). "Oxford Textbook of Medicine" (5th ed.). Edited by Warrel DA, Cox TM, Firth JD (published 2012). doi:10.1093/med/9780199204854.001.1. ISBN 978-0-19-920485-4. {{cite journal}}: Cite journal requires |journal= (help)
↑ Sipe, Jean D.; Benson, Merrill D.; Buxbaum, Joel N.; Ikeda, Shu-ichi; Merlini, Giampaolo; Saraiva, Maria J. M.; Westermark, Per (2014-12-01). "Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis". Amyloid. 21 (4): 221–224. doi:10.3109/13506129.2014.964858. ISSN 1744-2818. PMID 25263598. S2CID 41000320.

Other websites

National Press Club Luncheon with Michael York, August 2016. Michael York who has amyloidosis, speaks from 4:00-60:00

This short article about medicine can be made longer. You can help Wikipedia by adding to it.

[1] Wechalekar, Ashutosh D.; Gillmore, Julian D.; Hawkins, Philip N. (2015-12-21). "Systemic amyloidosis". Lancet (London, England). 387 (10038): 2641–2654. doi:10.1016/S0140-6736(15)01274-X. ISSN 1474-547X. PMID 26719234. S2CID 4762107.

[:3-2] 2.0 ^2.1 Pepys, Mark B. (2006-01-01). "Amyloidosis". Annual Review of Medicine. 57: 223–241. doi:10.1146/annurev.med.57.121304.131243. ISSN 0066-4219. PMID 16409147.

[:4-3] 3.0 ^3.1 Pepys MB and Hawkins PN, Amyloidosis (2010). Warrell, David A; Cox, Timothy M; Firth, John D (eds.). "Oxford Textbook of Medicine" (5th ed.). Edited by Warrel DA, Cox TM, Firth JD (published 2012). doi:10.1093/med/9780199204854.001.1. ISBN 978-0-19-920485-4. {{cite journal}}: Cite journal requires |journal= (help)

[:5-4] Sipe, Jean D.; Benson, Merrill D.; Buxbaum, Joel N.; Ikeda, Shu-ichi; Merlini, Giampaolo; Saraiva, Maria J. M.; Westermark, Per (2014-12-01). "Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis". Amyloid. 21 (4): 221–224. doi:10.3109/13506129.2014.964858. ISSN 1744-2818. PMID 25263598. S2CID 41000320.

[1]

[2]

[3]

[4]